Trinity Biotech plc received a Nasdaq non-compliance notice on February 11, 2026, for failing to maintain a $1.00 minimum bid price for its ADSs over 30 consecutive business days, violating Listing Rule 5450(a)(1). The company has 180 calendar days until August 10, 2026, to regain compliance by achieving $1.00 closing bid price for 10 consecutive business days, with ADSs continuing to trade on Nasdaq Global Select Market.
Key takeaways
Received Nasdaq notice on February 11, 2026, for non-compliance with Listing Rule 5450(a)(1)
Non-compliance based on closing bid price below $1.00 for last 30 consecutive business days
180 calendar day compliance period ending August 10, 2026
Must achieve $1.00 closing bid price for at least 10 consecutive business days to regain compliance
ADSs continue trading on Nasdaq Global Select Market under symbol TRIB
Management evaluating options to cure deficiency within grace period